The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity

Journal of Hypertension

Volumn 14, Issue 9, 1996, Pages 1093-1097

  Moan, Andreas ^a   Høieggen, Aud ^a   Seljeflot, Ingebjørg ^a   Risanger, Terje ^b   Arnesen, Harald ^a   Kjeldsen, Sverre E ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b Prinsdal Health Centre   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiotensin II; Antihypertensive therapy; AT1 receptor antagonism; Glucose metabolism; Insulin sensitivity

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOSARTAN POTASSIUM; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BORDERLINE HYPERTENSION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN SENSITIVITY; MALE; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029761763     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199609000-00008     Document Type: Article

References (25)

1. Devynck MA, Meyer P: Angiotensin receptors in vascular tissue. Am J Med 1976, 61:758-767.
2. Harris PG, Navar LG: Tubular transport responses to angiotensin. Am J Physiol 1985, 248: F261-F288.
3. Reams GP, Bauer JH: Angiotensin II potentiates the vasoconstrictive effect of noradrenaline in normotensive and hypertensive man. J Clin Hypertens 1987, 3:610-616.
4. Unger T, Badoer E, Ganten D, Lang RE, Rettiq R: Brain angiotensin: pathways and pharmacology. Circulation 1988, 77 (suppl I):I40-I54.
5. Singer DRJ, McGregor GA: Angioneurotic oedema associated with two angiotensin converting enzyme inhibitors. BMJ 1986, 293:1243.
6. Christen Y, Waeber B, Nussberger J, Lee RJ, Timmermans PB, Brunner HR: Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal volunteers. Circulation 1991, 83:1333-1342.
7. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990, 39: 167-174.
8. Ferranini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleqqini M, Graziadei L, et al.: Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350-357.
9. DeFronzo RA: Insulin resistance: the metabolic link between non-insulin-dependent diabetes mellitus, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Curr Opin Cardiol 1990, 5:586-593.
10. Reaven GM: Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J 1991, 121:1283-1289.
11. Gans RO, van der Toorn L, Bilo HJG, Nauta JJ, Heine RJ, Donher AJ: Renal and cardiovascular effects of exogenous insulin in healthy volunters. Clin Sci 1991, 80:219-225.
12. Lithell H: Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diabetes Care 1991, 14:203-209.
13. Moan A, Risanger T, Eide I, Kjeldsen SE: The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension. Blood Pressure 1994, 3:185-188.
14. DeFronzo R, Tobin J, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237: E214-E223.
15. Moan A, Nordby G, Os I, Birkeland K, Kjeldsen SE: Relationship between hemorheological factors and insulin sensitivity in healthy young men. Metabolism 1994, 43:423-427.
16. Johnson RN, Metcalf PA, Baker JR: Fructosamin: a new approach to the evaluation of serum glycosylprotein. An index of diabetic control. Clin Chem Acta 1982, 127:89-95.
17. Rostrup M, Kjeldsen SE, Eide I: Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test. Am J Hypertens 1990, 3:912-917.
18. Kahn CR: Role of insulin receptors in insulin resistant states. Metabolism 1980, 29:455-466.
19. Crettaz M, Jeanraud B: Postreceptor alterations in the states of insulin resistance. Metabolism 1980, 29:467-477.
20. Schultz TA, Lewis BL, Westbie DK: Glucose Delivery: a modulator of glucose uptake in contracting skeletal muscle. Am J Physiol 1977, 233: E514-E518.
21. Laakso M, Edelman V, Brechtel G, Baron AD: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 1990, 85: 1844-1852.
22. Baron AD, Laakso M, Brechtel G, Hoit B, Watt L, Edelman SV: Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab 1990, 79: 1525-1533.
23. Julius S, Gudbrandsson T, Jamerson K, Andersson O: The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Pressure 1992, 1:9-19.
24. Moan A, Høieggen A, Nordby G, Birkeland K, Eide I, Kjeldsen SE: The glucose clamp procedure activates the sympathetic nervous system even in the absence of hyperinsulinemia. J Clin Endocrin Metab 1995, 80:3151-3154.
25. Nordby G, Moan A, Kjeldsen SE, Eide I, Os I: Insulin resistance and sympathetic nervous system activity in hypertensive and normotensive women. Blood Pressure 1995, 4:287-292.